Title
Analiza odabranih markera glioblastroma
Creator
Jovanović, Nikola, 1990-
CONOR:
74988297
Copyright date
2021
Object Links
Select license
Autorstvo-Nekomercijalno-Bez prerade 3.0 Srbija (CC BY-NC-ND 3.0)
License description
Dozvoljavate samo preuzimanje i distribuciju dela, ako/dok se pravilno naznačava ime autora, bez ikakvih promena dela i bez prava komercijalnog korišćenja dela. Ova licenca je najstroža CC licenca. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/deed.sr_LATN. Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/legalcode.sr-Latn
Language
Serbian
Cobiss-ID
Theses Type
Doktorska disertacija
description
Datum odbrane: 27.09.2021.
Other responsibilities
Academic Expertise
Prirodno-matematičke nauke
Academic Title
-
University
Univerzitet u Nišu
Faculty
Prirodno-matematički fakultet
Group
Odsek za biologiju i ekologiju
Alternative title
Analysis of selected glioblastoma markers : doctoral dissertation
Publisher
[N. M. Jovanović]
Format
[17], 222 lista
description
Biobibliografija autora: listovi 215-219;
Bibliografija: listovi 176-201.
description
Molecular biology
Abstract (en)
Glioblastomas (GBM) represent one of the most aggressive types of diffuse glioma. Although they usually arise as primary brain tumors, in 10% of GBM cases, they develop from low-grade astrocytomas (secondary GBM). They express striking morphological heterogeneity, which is often encountered during a histopathological examination. Due to advances in molecular diagnostics, significant progress was made in understanding the pathogenesis of tumor growth and the development of personalized therapeutic protocols. The aim of this study was to evaluate the diagnostic, prognostic, and predictive properties of the selected markers -IDH1/2 (isocitrate-dehydrogenase 1 and 2) mutation and MGMT (O6-methylguanine-DNA methyltransferase) and CHI3L1 (Chitinase-3-like protein 1) methylation status of the promoter regions in a Serbian population of GBM patients. Patients operated on the Neurosurgery Clinic (The University Clinical Centre of Niš, Serbia) between 2013 and 2019 were included in this study. Sanger direct sequencing was used to detect the presence of IDH1/2 mutations in samples and conventional and Real-Time methylation-specific polymerase chain reaction methods for methylation status evaluation. Age, the extent of tumor resection, and type of adjuvant chemotherapy were recognized as independent prognostic factors in GBM patients. Furthermore, results suggested the superiority of adjuvant Temozolomide over adjuvant chemotherapy with a nitrosourea-based protocol (PCV and BCNU). IDH1 mutation was detected in 6.67% (3/45) of patients and was associated with more prolonged overall survival, younger age, and hypermethylation of the MGMT and CHI3L1 promoter. Semi-quantitative MSP approaches resulted in improved detection sensitivity of MGMT methylation status compared to the qualitative MSP method. Among IDH-wt homogenous cohort of GBM patients older than 50 years with complete/partial resection of the tumor, overall survival of patients harboring highly methylated MGMT was significantly longer in comparison with the unmethylated group. Complementary evaluation of CHI3L1 promoter methylation status potentially increases the prognostic value of the MGMT methylation status, which should be further investigated in more comprehensive research.
Authors Key words
glioblastom, prognostički faktor, IDH1/2 mutacija, metilacija MGMT, metilacija CHI3L1, metilaciono specifična polimerazna lančana reakcija (MSP), Temozolomid
Authors Key words
Glioblastoma, prognostic factor, IDH1/2 mutation, MGMT promoter methylation, CHI3L1 promoter methylation, Methylation-specific polymerase chain reaction (MSP), Temozolomide
Classification
611.81:616-006.04 (043.3)
Subject
B 007; B 220; B 726; B 790; P 320; T 490
Type
Tekst
Abstract (en)
Glioblastomas (GBM) represent one of the most aggressive types of diffuse glioma. Although they usually arise as primary brain tumors, in 10% of GBM cases, they develop from low-grade astrocytomas (secondary GBM). They express striking morphological heterogeneity, which is often encountered during a histopathological examination. Due to advances in molecular diagnostics, significant progress was made in understanding the pathogenesis of tumor growth and the development of personalized therapeutic protocols. The aim of this study was to evaluate the diagnostic, prognostic, and predictive properties of the selected markers -IDH1/2 (isocitrate-dehydrogenase 1 and 2) mutation and MGMT (O6-methylguanine-DNA methyltransferase) and CHI3L1 (Chitinase-3-like protein 1) methylation status of the promoter regions in a Serbian population of GBM patients. Patients operated on the Neurosurgery Clinic (The University Clinical Centre of Niš, Serbia) between 2013 and 2019 were included in this study. Sanger direct sequencing was used to detect the presence of IDH1/2 mutations in samples and conventional and Real-Time methylation-specific polymerase chain reaction methods for methylation status evaluation. Age, the extent of tumor resection, and type of adjuvant chemotherapy were recognized as independent prognostic factors in GBM patients. Furthermore, results suggested the superiority of adjuvant Temozolomide over adjuvant chemotherapy with a nitrosourea-based protocol (PCV and BCNU). IDH1 mutation was detected in 6.67% (3/45) of patients and was associated with more prolonged overall survival, younger age, and hypermethylation of the MGMT and CHI3L1 promoter. Semi-quantitative MSP approaches resulted in improved detection sensitivity of MGMT methylation status compared to the qualitative MSP method. Among IDH-wt homogenous cohort of GBM patients older than 50 years with complete/partial resection of the tumor, overall survival of patients harboring highly methylated MGMT was significantly longer in comparison with the unmethylated group. Complementary evaluation of CHI3L1 promoter methylation status potentially increases the prognostic value of the MGMT methylation status, which should be further investigated in more comprehensive research.
“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.